University of PittsburghUniversity of Pittsburgh
Startups
TechnologiesStartupsExpress LicensesCollectionsChat with AI
Sign in
University of Pittsburgh

Globin Solutions, Inc.

OverviewRequest InfoMore Like ThisExpress Licenses

Sector

Therapeutics

Funding Stage

Series A+

Founders

Mark T. GladwinJason J. RoseJesus Tejero Bravo

Website

https://www.globinsolutions.com/

Globin Solutions is developing a fast-acting antidote for carbon monoxide poisoning. Founded by University of Pittsburgh scientists Mark T. Gladwin, Jason J. Rose and Jesús Tejero Bravo, the company uses engineered neuroglobin designed to bind and remove carbon monoxide from blood. [1] [2]

Its preclinical program builds on animal research and aims to create a medicine that could complement oxygen-based care. More than $5 million in Series A financing and an NIH Fast-Track STTR award of up to $1.75 million have supported the company’s development work with Pitt. [3] [4] [5]

Discover More with AI